Industry resources and insights

Sort by year
  • All time
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016 and older
Insider Insights
06.12.2022
France – Clinical trials: an improved 2021 but t...

France have improved the conduction of clinical trials in 2021, due to the reduction of regulatory d...

Read more
Insider Insights
06.12.2022
UK NHS England set to eliminate hepatitis C by 203...

NHS England has reported that following a 5-year £1b antiviral drugs deal, deaths from Hepatitis C ...

Read more
Articles
30.11.2022
Reflecting on the Pricing & Market Access tre...

Our experts reflect on the trends that shaped the European pricing and market access landscape in 20...

Read more
Newsletter
16.11.2022
PMA Insights: Week 46 SPECIAL EDITION ISPOR 2022 R...

We summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...

Read more
Publications
09.11.2022
ISPOR 2022 Plenary Session 3 - Integrating Data

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...

Read more
Publications
08.11.2022
ISPOR 2022 Plenary Session 2 - Real-World Research

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on real-world patient-cent...

Read more
Load more
Browse by topic
  • Biosimilars
  • Devices & Diagnostics
  • Digital Health
  • Early Access
  • Emerging & Developing Markets
  • Funding
  • Gene Therapy & ATMPs
  • HTA
  • International Reference Pricing
  • Launch
  • Managed Entry Agreements
  • NICE
  • Oncology
  • Orphan Drugs
  • PMA Trends
  • Pricing
  • Rare Diseases
  • Real World Evidence
  • Team Remap
  • Training
Content type
  • All
  • Articles
  • Insider Insights
  • News
  • Newsletter
  • Publications
Subscribe
Consent